IC<sub>50</sub> values of the H32-DM1 series and H32-VCMMAE series.

NIAID Data Ecosystem2026-03-12 收录

数据链接：

https://figshare.com/articles/dataset/IC_sub_50_sub_values_of_the_H32-DM1_series_and_H32-VCMMAE_series_/13014772 数据链接链接失效反馈

官方服务：

资源简介：

IC50 values of the H32-DM1 series and H32-VCMMAE series.

创建时间：

2020-09-28

SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance

肿瘤靶向治疗

药物耐药机制

Protein arginine methyltransferase 5 (PRMT5) over-expression in hematological and solid tumors methylates arginine residues on cellular proteins involved in important cancer functions including cell c

NIAID Data Ecosystem90

Original images underlying Fig 3D.

肿瘤靶向治疗

RNA干扰

Expression of Concern: Specific Inhibition of Tumor Cells by Oncogenic EGFR Specific Silencing by RNA interference

Figshare2024-12-13 更新50

Urine Tx-M and PGI-M concentrations in ADAT participants categorized by treatment adherence, group assignment, and aspirin use.

药物药效评估

尿生物标志物

Two-way ANOVAs were performed for each eicosanoid in compliant and non-compliant subjects for the three treatment groups. Group assignment was significantly (+P<0.0001) related to urine Tx-M and PGI-M

NIAID Data Ecosystem40

肿瘤靶分子临床研究信息数据集

肿瘤靶向治疗

临床研究

聚焦肿瘤靶分子临床研究全流程，整合靶点发现、临床试验设计、疗效数据、安全性评估等核心信息。数据经标准化清洗与专业校验，关联靶点分子结构、作用机制及临床结果，支持科研机构靶点验证、药企药物研发、临床机构方案优化，为靶分子临床转化提供高质量、可溯源的数据支撑。

江苏数据交易所80

Bayesian Model Comparison Results for Three Response Models

贝叶斯模型

药物药效评估

Posterior Probabilities and Protected Exceedance Probabilities obtained from Bayesian Model Comparison of three alternative Response Models described in Marshall et al.Data are drug-group x response m

Figshare2016-09-02 更新40

IC<sub>50</sub> values of the H32-DM1 series and H32-VCMMAE series.

资源简介：

相关数据集